APP and Alzheimer disease: Moreover, some evidence suggest that the MAPK pathway could be involved in Tau hyperphosphorylation in AD [23], as well as in the amyloidogenic processing of the amyloid precursor protein (APP) that generates Aβ1–42 [21].